10/12/2019
1st IBDH Annual APP Symposium – Seattle 2019
Presented in partnership with: 
1st Annual IBDHorizons Nursing & Advanced Practice Provider Symposium
This Symposium aims at all health care providers involved in the care of IBD patients, including nurses, nurse practitioners, physician assistants, pharmacists, dieticians, in addition to physicians and gastroenterologists. It is an opportunity not to be missed to meet and discuss key topics with a highly select group of 150-180 colleagues. A practical approach to IBD.
October 12
Details
- Start: October 12 2019, 8:00 am
- End: October 12 2019, 3:30 pm
- Cost: Free of Charge - Pharmacists will pay a certification fee.
- Credits: 5.5 CME / CE credits
Housing
- Seattle Marriott Waterfront 2100 Alaskan Way, Seattle, WA 98121 – (800) 228-9290
- We recommend going online for best rates
Parking
Topics
| Topics | Speakers |
|---|---|
| Diagnostic Testing in IBD and Risk Stratification | Ghassan Wahbeh, MD |
| Update on Diet & IBD | Dale Lee, MD |
| Starting & Monitoring Therapy with Mesalamine & Immune Modulators | Michael Chiorean, MD |
| Health maintenance for IBD patients | Kindra Clark-Snustad, DNP, ARNP |
| The Expanding Role of the Pharmacist in Managing Patients with IBD | Sonia Hussain |
| Beyond Conventional Therapy in IBD | Scott D. Lee, MD |
| How to Obtain Advanced Therapy Including Biologics for an IBD Patient | Betty White, MN, ARNP |
| Guide for Traveling for Patients With IBD | Teresa Wachs, RN |
| Understanding Ostomies | Jason Harper, MD |
Venue : Bell Harbor International Conference Center
Learning Objectives
- Explain which diagnostic tests are best for the initial diagnosis of IBD.
- Explain how to interpret diagnostic testing when evaluating a patient for IBD.
- Appropriately choose the patients in whom to initiate, how to initiate, how to monitor and potential side effects of mesalamine, thiopurines and methotrexate in IBD.
- Describe the safety and efficacy of available biologics.
- Choose which biologic is appropriate for any given IBD patient.
- Explain the implications of the availability of biosimilars.
- Describe how to navigate the insurance approval for a biologic, including utilizing co-pay assistance or patient assistance programs.
- Explain how to take specific precautions for patients with IBD traveling abroad, including how to travel with a biologic medication.
- Explain a pharmacist’s role in treating and monitoring patients with IBD.
- Explain the standard of care for health maintenance for IBD patients with special considerations including cancer screening and immunizations for those on immune suppressive or biologic therapies.
- Describe the types of ostomies IBD patients might have and how to manage ostomies or complications.
Media
This activity is jointly provided by IBDHorizons and Indiana University School of Medicine
This activity is supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Pfizer Inc.
CME Supporters
Platinum
Gold
Exhibitors
Platinum
Gold
Target Audience
Gastroenterologists, advanced nurse practitioners, physician assistants, gastroenterology nurses involved in the care of patients with IBD.
Statement of Need/Program Overview
This activity is jointly provided by IBDHorizons and Indiana University School of Medicine
Credits
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and IBDHorizons. Indiana University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses
Indiana University School of Medicine designates this activity for a maximum of 5.5 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Physicians
Indiana University School of Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.